Infliximab Versus Conventional Combination Treatment and Seven‐Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial

OBJECTIVE: To compare long‐term work loss in methotrexate‐refractory early rheumatoid arthritis (RA) patients randomized to the addition of infliximab or conventional combination treatment. METHODS: This study was a multicenter, 2‐arm, parallel, randomized, active‐controlled, open‐label trial. RA pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Jonas K., Wallman, Johan K., Miller, Heather, Petersson, Ingemar F., Ernestam, Sofia, Vivar, Nancy, van Vollenhoven, Ronald F., Neovius, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767553/
https://www.ncbi.nlm.nih.gov/pubmed/27015295
http://dx.doi.org/10.1002/acr.22899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767553/
https://www.ncbi.nlm.nih.gov/pubmed/27015295
http://dx.doi.org/10.1002/acr.22899

Ejemplares similares